Company intelligence / Profile preview

Ascend Advanced Therapies

London, England, United Kingdom

Ownership: Private
Employees: ~120
Development stage: Other

Overview

Ascend Advanced Therapies serves as a specialist CDMO focused on adeno-associated virus (AAV) gene and cell therapies, offering process development, GMP manufacturing (up to commercial scale), analytical and regulatory support for advanced modality therapies. It operates as a manufacturing partner for clinical to commercial programs, rather than running its own clinical programs or publishing direct clinical results.[1][4][5][7]

Modalities: Gene therapyCell therapyAdeno-associated virus vector
Industry: Contract Manufacturing Organization

Partnerships

Beacon TherapeuticsABL, Inc.

Beyond the preview

Go deeper on Ascend Advanced Therapies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ascend Advanced Therapies.

Explore the full profile